A bill to provide that no funds may be expended by the United States Trade Representative to negotiate data exclusivity provisions for certain pharmaceutical products.
About This Bill
Committee
Latest Action · October 8, 2004
Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S10848)